Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | cytochrome p450-like protein | 0.004 | 0.0083 | 0.0083 |
Brugia malayi | Zinc finger, C2H2 type family protein | 0.0463 | 0.3743 | 0.3743 |
Wolbachia endosymbiont of Brugia malayi | dihydroorotate dehydrogenase 2 | 0.1187 | 1 | 0.5 |
Trypanosoma brucei | dihydroorotate dehydrogenase (fumarate) | 0.1187 | 1 | 1 |
Echinococcus multilocularis | cAMP and cAMP inhibited cGMP 3',5' cyclic | 0.025 | 0.1898 | 0.507 |
Brugia malayi | Cytochrome P450 family protein | 0.004 | 0.0083 | 0.0083 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0133 | 0.0883 | 0.4823 |
Trypanosoma brucei | cytochrome P450, putative | 0.004 | 0.0083 | 0.0083 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.004 | 0.0083 | 0.0083 |
Brugia malayi | Probable 3',5'-cyclic phosphodiesterase C32E12.2, putative | 0.025 | 0.1898 | 0.1898 |
Echinococcus multilocularis | dihydropyrimidine dehydrogenase (NADP+) | 0.0463 | 0.3743 | 1 |
Mycobacterium ulcerans | dihydroorotate dehydrogenase 2 | 0.1187 | 1 | 1 |
Brugia malayi | Dihydroorotate dehydrogenase, mitochondrial precursor, putative | 0.1187 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0242 | 0.183 | 1 |
Trypanosoma cruzi | dihydroorotate dehydrogenase (fumarate), putative | 0.1187 | 1 | 1 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0463 | 0.3743 | 0.5 |
Leishmania major | dihydroorotate dehydrogenase | 0.1187 | 1 | 1 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0463 | 0.3743 | 0.5 |
Brugia malayi | Cytochrome P450 family protein | 0.0133 | 0.0883 | 0.0883 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0463 | 0.3743 | 0.5 |
Loa Loa (eye worm) | CYP4Cod1 | 0.004 | 0.0083 | 0.0455 |
Echinococcus granulosus | dihydropyrimidine dehydrogenase NADP | 0.0463 | 0.3743 | 1 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0463 | 0.3743 | 0.5 |
Trypanosoma cruzi | cytochrome P450, putative | 0.004 | 0.0083 | 0.0083 |
Toxoplasma gondii | dihydroorotate dehydrogenase reveal, putative | 0.1187 | 1 | 1 |
Entamoeba histolytica | dihydropyrimidine dehydrogenase, putative | 0.0463 | 0.3743 | 0.5 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.004 | 0.0083 | 0.0455 |
Trypanosoma cruzi | dihydroorotate dehydrogenase, putative | 0.0463 | 0.3743 | 0.3743 |
Trypanosoma cruzi | dihydroorotate dehydrogenase, putative | 0.1187 | 1 | 1 |
Trypanosoma cruzi | cytochrome P450, putative | 0.004 | 0.0083 | 0.0083 |
Mycobacterium leprae | Probable dihydroorotate dehydrogenase PyrD | 0.1187 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0222 | 0.1654 | 0.904 |
Echinococcus granulosus | cAMP and cAMP inhibited cGMP 3'5' cyclic | 0.025 | 0.1898 | 0.507 |
Echinococcus granulosus | dihydropyrimidine dehydrogenase NADP | 0.0463 | 0.3743 | 1 |
Plasmodium vivax | dihydroorotate dehydrogenase, mitochondrial precursor, putative | 0.1187 | 1 | 0.5 |
Echinococcus multilocularis | dihydropyrimidine dehydrogenase (NADP+) | 0.0463 | 0.3743 | 1 |
Schistosoma mansoni | dihydroorotate dehydrogenase | 0.1187 | 1 | 1 |
Plasmodium falciparum | dihydroorotate dehydrogenase | 0.1187 | 1 | 0.5 |
Mycobacterium tuberculosis | Probable dihydroorotate dehydrogenase PyrD | 0.1187 | 1 | 1 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0463 | 0.3743 | 0.5 |
Brugia malayi | Cytochrome P450 family protein | 0.004 | 0.0083 | 0.0083 |
Trichomonas vaginalis | dihydropyrimidine dehydrogenase, putative | 0.0463 | 0.3743 | 0.5 |
Trypanosoma cruzi | dihydroorotate dehydrogenase, putative | 0.1187 | 1 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.004 | 0.0083 | 0.0455 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
LD50 (ADMET) | = 21 mg kg-1 | Toxicity estimated in mouse as LD50 by intravenous administration | ChEMBL. | 7205883 |
LD50 (ADMET) | = 21 mg kg-1 | Toxicity estimated in mouse as LD50 by intravenous administration | ChEMBL. | 7205883 |
SRR (functional) | 0 % | Activity against ouabain-induced ventricular arrhythmia of the compound was measured as percent of sinus rhythm recovery; Inactive | ChEMBL. | 7205883 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.